Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials

S Saboori, S Shab-Bidar, J R Speakman, E Yousefi Rad, K Djafarian

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

C-reactive protein (CRP), a marker of chronic inflammation, has a major role in the etiology of chronic disease. Vitamin E may have anti-inflammatory effects. However, there is no consensus on the effects of vitamin E supplementation on CRP levels in clinical trials. The aim of this study was to systematically review randomized controlled trials (RCTs) that report on the effects of vitamin E supplementation (α- and γ-tocopherols) on CRP levels. A systematic search of RCTs was conducted on Medline and EMBASE through PubMed, Scopus, Ovid and Science Direct, and completed by a manual review of the literature up to May 2014. Pooled effects were estimated by using random-effects models and heterogeneity was assessed by Cochran's Q and I(2) tests. Subgroup analyses and meta-regression analyses were also performed according to intervention duration, dose of supplementation and baseline level of CRP. Of 4734 potentially relevant studies, only 12 trials met the inclusion criteria with 246 participants in the intervention arms and 249 participants in control arms. Pooled analysis showed a significant reduction in CRP levels of 0.62 mg/l (95% confidence interval = -0.92, -0.31; P < 0.001) in vitamin E-treated individuals, with the evidence of heterogeneity across studies. This significant effect was maintained in all subgroups, although the univariate meta-regression analysis showed that the vitamin E supplementation dose, baseline level of CRP and duration of intervention were not the sources of the observed heterogeneity. The results of this meta-analysis suggest that supplementation with vitamin E in the form of either α-tocopherol or γ-tocopherol would reduce serum CRP levels.

Original languageEnglish
Pages (from-to)867-73
Number of pages7
JournalEuropean Journal of Clinical Nutrition
Volume69
Issue number8
Early online date11 Feb 2015
DOIs
Publication statusPublished - Aug 2015

Fingerprint

Vitamin E
C-Reactive Protein
Meta-Analysis
Blood Proteins
Randomized Controlled Trials
Tocopherols
Regression Analysis
PubMed
Chronic Disease
Anti-Inflammatory Agents
Clinical Trials
Confidence Intervals
Inflammation

Keywords

  • Anti-Inflammatory Agents
  • Biomarkers
  • C-Reactive Protein
  • Dietary Supplements
  • Humans
  • Inflammation
  • Randomized Controlled Trials as Topic
  • Vitamins
  • alpha-Tocopherol
  • gamma-Tocopherol

Cite this

Effect of vitamin E supplementation on serum C-reactive protein level : a meta-analysis of randomized controlled trials. / Saboori, S; Shab-Bidar, S; Speakman, J R; Yousefi Rad, E; Djafarian, K.

In: European Journal of Clinical Nutrition, Vol. 69, No. 8, 08.2015, p. 867-73.

Research output: Contribution to journalArticle

@article{fda55bd265df45f3b6d4041faaee703a,
title = "Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials",
abstract = "C-reactive protein (CRP), a marker of chronic inflammation, has a major role in the etiology of chronic disease. Vitamin E may have anti-inflammatory effects. However, there is no consensus on the effects of vitamin E supplementation on CRP levels in clinical trials. The aim of this study was to systematically review randomized controlled trials (RCTs) that report on the effects of vitamin E supplementation (α- and γ-tocopherols) on CRP levels. A systematic search of RCTs was conducted on Medline and EMBASE through PubMed, Scopus, Ovid and Science Direct, and completed by a manual review of the literature up to May 2014. Pooled effects were estimated by using random-effects models and heterogeneity was assessed by Cochran's Q and I(2) tests. Subgroup analyses and meta-regression analyses were also performed according to intervention duration, dose of supplementation and baseline level of CRP. Of 4734 potentially relevant studies, only 12 trials met the inclusion criteria with 246 participants in the intervention arms and 249 participants in control arms. Pooled analysis showed a significant reduction in CRP levels of 0.62 mg/l (95{\%} confidence interval = -0.92, -0.31; P < 0.001) in vitamin E-treated individuals, with the evidence of heterogeneity across studies. This significant effect was maintained in all subgroups, although the univariate meta-regression analysis showed that the vitamin E supplementation dose, baseline level of CRP and duration of intervention were not the sources of the observed heterogeneity. The results of this meta-analysis suggest that supplementation with vitamin E in the form of either α-tocopherol or γ-tocopherol would reduce serum CRP levels.",
keywords = "Anti-Inflammatory Agents, Biomarkers, C-Reactive Protein, Dietary Supplements, Humans, Inflammation, Randomized Controlled Trials as Topic, Vitamins, alpha-Tocopherol, gamma-Tocopherol",
author = "S Saboori and S Shab-Bidar and Speakman, {J R} and {Yousefi Rad}, E and K Djafarian",
note = "Conflict of interest The authors declare no conflict of interest.",
year = "2015",
month = "8",
doi = "10.1038/ejcn.2014.296",
language = "English",
volume = "69",
pages = "867--73",
journal = "European Journal of Clinical Nutrition",
issn = "0954-3007",
publisher = "NATURE PUBLISHING GROUP",
number = "8",

}

TY - JOUR

T1 - Effect of vitamin E supplementation on serum C-reactive protein level

T2 - a meta-analysis of randomized controlled trials

AU - Saboori, S

AU - Shab-Bidar, S

AU - Speakman, J R

AU - Yousefi Rad, E

AU - Djafarian, K

N1 - Conflict of interest The authors declare no conflict of interest.

PY - 2015/8

Y1 - 2015/8

N2 - C-reactive protein (CRP), a marker of chronic inflammation, has a major role in the etiology of chronic disease. Vitamin E may have anti-inflammatory effects. However, there is no consensus on the effects of vitamin E supplementation on CRP levels in clinical trials. The aim of this study was to systematically review randomized controlled trials (RCTs) that report on the effects of vitamin E supplementation (α- and γ-tocopherols) on CRP levels. A systematic search of RCTs was conducted on Medline and EMBASE through PubMed, Scopus, Ovid and Science Direct, and completed by a manual review of the literature up to May 2014. Pooled effects were estimated by using random-effects models and heterogeneity was assessed by Cochran's Q and I(2) tests. Subgroup analyses and meta-regression analyses were also performed according to intervention duration, dose of supplementation and baseline level of CRP. Of 4734 potentially relevant studies, only 12 trials met the inclusion criteria with 246 participants in the intervention arms and 249 participants in control arms. Pooled analysis showed a significant reduction in CRP levels of 0.62 mg/l (95% confidence interval = -0.92, -0.31; P < 0.001) in vitamin E-treated individuals, with the evidence of heterogeneity across studies. This significant effect was maintained in all subgroups, although the univariate meta-regression analysis showed that the vitamin E supplementation dose, baseline level of CRP and duration of intervention were not the sources of the observed heterogeneity. The results of this meta-analysis suggest that supplementation with vitamin E in the form of either α-tocopherol or γ-tocopherol would reduce serum CRP levels.

AB - C-reactive protein (CRP), a marker of chronic inflammation, has a major role in the etiology of chronic disease. Vitamin E may have anti-inflammatory effects. However, there is no consensus on the effects of vitamin E supplementation on CRP levels in clinical trials. The aim of this study was to systematically review randomized controlled trials (RCTs) that report on the effects of vitamin E supplementation (α- and γ-tocopherols) on CRP levels. A systematic search of RCTs was conducted on Medline and EMBASE through PubMed, Scopus, Ovid and Science Direct, and completed by a manual review of the literature up to May 2014. Pooled effects were estimated by using random-effects models and heterogeneity was assessed by Cochran's Q and I(2) tests. Subgroup analyses and meta-regression analyses were also performed according to intervention duration, dose of supplementation and baseline level of CRP. Of 4734 potentially relevant studies, only 12 trials met the inclusion criteria with 246 participants in the intervention arms and 249 participants in control arms. Pooled analysis showed a significant reduction in CRP levels of 0.62 mg/l (95% confidence interval = -0.92, -0.31; P < 0.001) in vitamin E-treated individuals, with the evidence of heterogeneity across studies. This significant effect was maintained in all subgroups, although the univariate meta-regression analysis showed that the vitamin E supplementation dose, baseline level of CRP and duration of intervention were not the sources of the observed heterogeneity. The results of this meta-analysis suggest that supplementation with vitamin E in the form of either α-tocopherol or γ-tocopherol would reduce serum CRP levels.

KW - Anti-Inflammatory Agents

KW - Biomarkers

KW - C-Reactive Protein

KW - Dietary Supplements

KW - Humans

KW - Inflammation

KW - Randomized Controlled Trials as Topic

KW - Vitamins

KW - alpha-Tocopherol

KW - gamma-Tocopherol

U2 - 10.1038/ejcn.2014.296

DO - 10.1038/ejcn.2014.296

M3 - Article

C2 - 25669317

VL - 69

SP - 867

EP - 873

JO - European Journal of Clinical Nutrition

JF - European Journal of Clinical Nutrition

SN - 0954-3007

IS - 8

ER -